Gut microbiota-based discriminative model for patients with ulcerative colitis: A meta-analysis and real-world study

Rong Zhang,Jing Chen,Li Liu,Xiankun Li,Changwei Qiu
DOI: https://doi.org/10.1097/md.0000000000037091
IF: 1.6
2024-03-09
Medicine
Abstract:Ulcerative colitis (UC) is a disorder of unknown cause characterized by inflammation starting in the rectum and spreading to the rest of the colon mucosa. [ 1 , 2 ] UC therapy can be divided into 2 categories: induction and maintenance therapies. The primary objective of treatment is to attain or maintain clinical and endoscopic remission, reduce the incidence of complications, and improve patient quality of life. [ 1 , 3 ] UC is classified into 3 categories based on severity: mild, moderate, or severe. Lesions associated with UC can be categorized as proctitis, left-sided colitis, or pancolitis. Treatment strategies for UC vary depending on the severity of the disease and the range of lesions. [ 3 ] Nonbiological drugs are critical components of UC treatment, and biological drugs have become increasingly effective in recent years. [ 4 , 5 ] Surgery remains the sole treatment for UC, with approximately 15% of patients necessitating coloproctectomy. Clinically, surgery is recommended only in specific cases, including refractory UC or neoplastic lesions. [ 3 , 5 ]
medicine, general & internal
What problem does this paper attempt to address?